Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 10 studies | 30% ± 11% | |
| endothelial cell | 7 studies | 23% ± 6% | |
| macrophage | 5 studies | 24% ± 3% | |
| neuron | 4 studies | 30% ± 13% | |
| GABAergic neuron | 4 studies | 38% ± 13% | |
| astrocyte | 4 studies | 24% ± 8% | |
| glutamatergic neuron | 4 studies | 52% ± 18% | |
| microglial cell | 3 studies | 19% ± 2% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 8% | |
| interneuron | 3 studies | 36% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 6 studies | 39% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2423.71 | 1445 / 1445 | 100% | 12.69 | 183 / 183 |
| brain | 100% | 3826.22 | 2641 / 2642 | 100% | 14.30 | 705 / 705 |
| lung | 100% | 3372.38 | 578 / 578 | 100% | 10.43 | 1152 / 1155 |
| breast | 100% | 2130.20 | 459 / 459 | 100% | 9.36 | 1115 / 1118 |
| thymus | 100% | 1698.08 | 652 / 653 | 100% | 7.01 | 602 / 605 |
| uterus | 100% | 2539.63 | 170 / 170 | 99% | 10.04 | 456 / 459 |
| intestine | 100% | 2473.84 | 966 / 966 | 99% | 7.74 | 523 / 527 |
| skin | 100% | 3320.30 | 1809 / 1809 | 99% | 19.71 | 468 / 472 |
| kidney | 100% | 1977.90 | 89 / 89 | 98% | 6.85 | 887 / 901 |
| bladder | 100% | 2682.05 | 21 / 21 | 98% | 8.43 | 496 / 504 |
| prostate | 100% | 1900.70 | 245 / 245 | 98% | 5.26 | 493 / 502 |
| stomach | 99% | 1550.96 | 355 / 359 | 99% | 7.78 | 283 / 286 |
| adrenal gland | 100% | 1715.80 | 258 / 258 | 97% | 15.18 | 222 / 230 |
| ovary | 99% | 1535.73 | 179 / 180 | 96% | 7.02 | 413 / 430 |
| pancreas | 95% | 1115.06 | 311 / 328 | 98% | 7.12 | 175 / 178 |
| liver | 96% | 1214.81 | 218 / 226 | 96% | 5.35 | 391 / 406 |
| adipose | 100% | 2640.22 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.29 | 29 / 29 |
| muscle | 100% | 4888.75 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2533.32 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 10.85 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.97 | 1 / 1 |
| blood vessel | 100% | 2258.74 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 2392.44 | 853 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 7.35 | 71 / 80 |
| peripheral blood | 53% | 705.45 | 488 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
| GO_0090235 | Biological process | regulation of metaphase plate congression |
| GO_0030516 | Biological process | regulation of axon extension |
| GO_0043687 | Biological process | post-translational protein modification |
| GO_0000226 | Biological process | microtubule cytoskeleton organization |
| GO_0005876 | Cellular component | spindle microtubule |
| GO_0004835 | Molecular function | tubulin-tyrosine ligase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | TTL |
| Protein name | Tubulin--tyrosine ligase (TTL) (EC 6.3.2.25) |
| Synonyms | |
| Description | FUNCTION: Catalyzes the post-translational addition of a tyrosine to the C-terminal end of detyrosinated alpha-tubulin. . |
| Accessions | ENST00000233336.7 Q8NG68 |